These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

862 related items for PubMed ID: 23389892

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials.
    Kakkos SK, Kirkilesis GI, Tsolakis IA.
    Eur J Vasc Endovasc Surg; 2014 Nov; 48(5):565-75. PubMed ID: 24951377
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Practical management of new oral anticoagulants after total hip or total knee arthroplasty.
    Klauser W, Dütsch M.
    Musculoskelet Surg; 2013 Dec; 97(3):189-97. PubMed ID: 24249360
    [Abstract] [Full Text] [Related]

  • 8. Direct oral anticoagulants in the prevention of venous thromboembolism: evidence from major clinical trials.
    Prandoni P, Temraz S, Taher A.
    Semin Hematol; 2014 Apr; 51(2):121-30. PubMed ID: 24861796
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic and pharmacodynamic drug interactions with new oral anticoagulants: what do they mean for patients with atrial fibrillation?
    Hellwig T, Gulseth M.
    Ann Pharmacother; 2013 Nov; 47(11):1478-87. PubMed ID: 24259602
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. New oral anticoagulants for the treatment of venous thromboembolism.
    Agnelli G, Becattini C, Franco L.
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):151-61. PubMed ID: 23953903
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Direct oral anticoagulants: An update.
    Franco Moreno AI, Martín Díaz RM, García Navarro MJ.
    Med Clin (Barc); 2018 Sep 14; 151(5):198-206. PubMed ID: 29295790
    [Abstract] [Full Text] [Related]

  • 15. Moving toward a more ideal anticoagulant: the oral direct thrombin and factor Xa inhibitors.
    King CS, Holley AB, Moores LK.
    Chest; 2013 Apr 14; 143(4):1106-1116. PubMed ID: 23546483
    [Abstract] [Full Text] [Related]

  • 16. Long-term benefits of preventing venous thromboembolic events.
    Cohen AT.
    Curr Med Res Opin; 2012 Jun 14; 28(6):877-89. PubMed ID: 22533680
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evolving use of new oral anticoagulants for treatment of venous thromboembolism.
    Yeh CH, Gross PL, Weitz JI.
    Blood; 2014 Aug 14; 124(7):1020-8. PubMed ID: 24923298
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.